Search for: "Boehringer Ingelheim, Inc."
Results 101 - 120
of 155
Sorted by Relevance
|
Sort by Date
6 May 2024, 8:26 am
” Warning letters were sent to 10 manufacturers, including, among others, Teva (identifying 58 listings), Novo Nordisk (36 listings), and Boehringer Ingelheim (10 listings). [read post]
15 Jun 2012, 2:51 pm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
13 May 2009, 9:57 am
Boehringer Ingelheim case) and found that a broader standard should apply even though the employer's reading of various decisions. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
15 Jun 2012, 2:51 pm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
14 Jul 2010, 6:47 pm
Boehringer Ingelheim Pharma (EPLAW) Plavix (Clopidogrel) – US: Apotex’s second request for re-examination of Plavix patent denied by USPTO (Patent Docs) Tarka (Trandolapril, Verapamil) – Sanofi, Abbott successfully request sanctions against Glenmark in Tarka dispute (Patent Docs) [read post]
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]
12 Jan 2012, 4:21 am
Citing Case C-348/04 Boehringer Ingelheim KG v Swingward Ltd, it said the appropriate financial remedy should be assessed in the light of the extent of damage caused to Hollister by the infringement, this being assessed in accordance with the principle of proportionality. [read post]
17 Mar 2015, 3:09 am
Boehringer Ingelheim Pharmaceuticals, Inc.). [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
21 Apr 2021, 4:00 am
It is well established in trademark jurisprudence that the owner of a mark is not legally responsible for torts allegedly perpetrated by its user: Batten v Boehringer Ingelheim (Canada) Ltd., 2017 ONSC 53, at para. 153. [read post]
22 May 2009, 9:32 am
Flomax is manufactured by Boehringer Ingelheim Pharmaceuticals Inc. [read post]
16 Feb 2015, 3:44 am
Boehringer Ingelheim Pharmaceuticals, Inc., D. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
